Viewing Study NCT06380660

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-02-03 @ 3:32 AM
Study NCT ID: NCT06380660
Status: RECRUITING
Last Update Posted: 2025-05-18
First Post: 2024-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Sponsor: Acerand Therapeutics (Shanghai) Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor, Adult View
None BRCA1 Mutation View
None BRCA2 Mutation View
None Ovarian Cancer View
None Breast Cancer View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ACE-86225106 View
None advanced solid tumors View
None PARP inhibitor View
None BRCA mutation View
None breast cancer View
None ovarian cancer View
None CRPC View